STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297,190 | -62.9% | 75,429 | 0.0% | 0.04% | -60.2% |
| Q2 2023 | $801,810 | +27.6% | 75,429 | 0.0% | 0.11% | +18.9% |
| Q1 2023 | $628,324 | -9.8% | 75,429 | 0.0% | 0.10% | -12.8% |
| Q4 2022 | $696,210 | -60.1% | 75,429 | -44.6% | 0.11% | -62.7% |
| Q3 2022 | $1,747,000 | -17.4% | 136,039 | -15.0% | 0.29% | -15.4% |
| Q2 2022 | $2,114,000 | -37.2% | 160,000 | 0.0% | 0.34% | -26.6% |
| Q1 2022 | $3,368,000 | -12.2% | 160,000 | 0.0% | 0.47% | -8.7% |
| Q4 2021 | $3,838,000 | – | 160,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $9,991,000 | 2.07% |
| RTW INVESTMENTS, LP | 3,644,248 | $122,665,000 | 1.85% |
| Cormorant Asset Management, LP | 1,278,276 | $43,027,000 | 1.46% |
| Redmile Group, LLC | 2,458,558 | $82,755,000 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 233,135 | $7,847,000 | 0.53% |
| Birchview Capital, LP | 15,000 | $505,000 | 0.30% |
| Perceptive Advisors | 1,343,956 | $45,238,000 | 0.29% |
| GILDER GAGNON HOWE & CO LLC | 1,245,956 | $41,939,000 | 0.21% |
| Artal Group S.A. | 250,000 | $8,415,000 | 0.17% |
| Casdin Capital, LLC | 120,000 | $4,039,000 | 0.10% |